Aleafia Health Inc.
ALEAF
$0.00
$0.000.00%
| Weiss Ratings | ALEAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | ALEAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | ALEAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 98.32 | |||
| Price History | ALEAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -100.00% | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -100.00% | |||
| 2-Year Total Return | -100.00% | |||
| 3-Year Total Return | -100.00% | |||
| 5-Year Total Return | -100.00% | |||
| 52-Week High % Change | -99.00% | |||
| 52-Week Low % Change | 900.00% | |||
| Price | ALEAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Oct 24, 2024 | |||
| 52-Week High Price (Date) | Nov 22, 2024 | |||
| Valuation | ALEAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.06 | |||
| Earnings Per Share Growth | -80.03% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | -- | |||
| Dividends and Shares | ALEAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 402.31M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ALEAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 416 860 5665 | |||
| Address | 85 Basaltic Road Concord, ON L4K 1G4 | |||
| Website | www.aleafiahealth.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | ALEAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -39.53% | |||
| Profit Margin | -78.71% | |||
| Management Effectiveness | ALEAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -14.62% | |||
| Return on Equity | -- | |||
| Income Statement | ALEAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 32.42M | |||
| Total Revenue (TTM) | 32.42M | |||
| Revenue Per Share | $0.08 | |||
| Gross Profit (TTM) | 5.23M | |||
| EBITDA (TTM) | -8.27M | |||
| EBIT (TTM) | -12.82M | |||
| Net Income (TTM) | -25.52M | |||
| Net Income Avl. to Common (TTM) | -25.52M | |||
| Total Revenue Growth (Q YOY) | 74.51% | |||
| Earnings Growth (Q YOY) | -205.27% | |||
| EPS Diluted (TTM) | -0.06 | |||
| EPS Diluted Growth (Q YOY) | -182.46% | |||
| Balance Sheet | ALEAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 395.40K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 26.50M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -6.59M | |||
| Current Ratio (Q) | 1.006 | |||
| Book Value Per Share (Q) | -$0.02 | |||
| Total Assets (Q) | 44.29M | |||
| Total Current Liabilities (Q) | 26.34M | |||
| Total Debt (Q) | 34.25M | |||
| Total Liabilities (Q) | 50.88M | |||
| Total Common Equity (Q) | -6.59M | |||
| Cash Flow | ALEAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.07M | |||
| Cash from Financing (TTM) | 3.15M | |||
| Net Change in Cash (TTM) | -615.10K | |||
| Levered Free Cash Flow (TTM) | -5.48M | |||
| Cash from Operations (TTM) | -2.69M | |||
